PetMed Express, Inc. (NASDAQ:PETS) Stake Cut by Sei Investments Co.

Sei Investments Co. lessened its holdings in PetMed Express, Inc. (NASDAQ:PETS) by 62.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 16,600 shares of the company’s stock after selling 27,190 shares during the quarter. Sei Investments Co. owned approximately 0.08% of PetMed Express worth $80,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the business. R Squared Ltd bought a new stake in shares of PetMed Express in the 4th quarter worth approximately $31,000. Virtu Financial LLC acquired a new stake in shares of PetMed Express in the 4th quarter worth about $58,000. Finally, American Century Companies Inc. lifted its position in PetMed Express by 15.3% in the 4th quarter. American Century Companies Inc. now owns 33,662 shares of the company’s stock valued at $162,000 after purchasing an additional 4,459 shares during the last quarter. Institutional investors own 73.33% of the company’s stock.

Analyst Ratings Changes

Separately, StockNews.com downgraded PetMed Express from a “buy” rating to a “hold” rating in a research report on Tuesday, February 11th.

PetMed Express Trading Down 2.9 %

Shares of PetMed Express stock opened at $3.04 on Friday. PetMed Express, Inc. has a 52 week low of $2.90 and a 52 week high of $6.85. The company’s 50-day moving average price is $4.13 and its two-hundred day moving average price is $4.51. The stock has a market cap of $62.79 million, a PE ratio of 304.30 and a beta of 0.99.

PetMed Express (NASDAQ:PETS) last announced its quarterly earnings data on Monday, February 10th. The company reported ($0.03) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.02). PetMed Express had a net margin of 0.14% and a return on equity of 0.37%. On average, equities analysts predict that PetMed Express, Inc. will post 0.19 EPS for the current fiscal year.

PetMed Express Profile

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.